{"name":"NovalGen Ltd.","slug":"novalgen-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNaTRzRzlTVlZ3bEc5RUhKZFhCY09aYVFXX2RQU2sxQkpsWmoydG5CeUNiZWVkSEppbnJTM0xfUWNVWWl4VHlPRUswVE9aRm0zcTFjZzc2cTVRd1YtOXJZczZ5LTZ2VnlIbFpVcDZGU3FZNE5OTmU5dkx1T2VDRUNTMWNiblRNcEszdlladHJhdEdOQkk0UUVTVmxKRU0?oc=5","date":"2025-06-30","type":"deal","source":"Contract Pharma","summary":"Mabion, NovalGen Partner to Bring NVG-222 to Market - Contract Pharma","headline":"Mabion, NovalGen Partner to Bring NVG-222 to Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOMm1WWldhcG5GSlN5NGRVNGQ1OUs3anBFOUoxSHlqWmJJZThncXNlV1FmWktXbW9hc1RHS2hlOXNkd3htaDhFbHdQbThLZVFpSVVvMWV6b3JmR2ZXd3Z1eVBJVmtrUURnejZfNG96dG4wVkYxZE1iR3FLZ2NCYmxEUGtxY0laeTJZVlE?oc=5","date":"2025-06-30","type":"pipeline","source":"Manufacturing Chemist","summary":"Mabion tapped as CDMO of choice for manufacture of NovalGen's T-cell engager - Manufacturing Chemist","headline":"Mabion tapped as CDMO of choice for manufacture of NovalGen's T-cell engager","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNUWN4YUpOMXprNFUyWGtabFZaRHViYS1xN3BXS3hEUU5mT2czS2hodFZFWExMY2JqTzhBbXhDVVUyd2hPTHRmUHMwZjNvdDJZVXFlYVp0RXNUMHdWVlZhNDNwNnNlVjJnbEFBQnJTc0Z0UXRrUy1zNjVHVVlDem9ENFBNSVRKSnpWRjBveVEtdTlaNXgwUzc4?oc=5","date":"2021-02-22","type":"deal","source":"Contract Pharma","summary":"NovalGen and Halix Enter Strategic Partnership - Contract Pharma","headline":"NovalGen and Halix Enter Strategic Partnership","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}